REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,000 | -50.0% | 1,800 | -48.6% | 0.00% | -100.0% |
| Q2 2015 | $2,000 | -33.3% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $3,000 | -40.0% | 3,500 | -50.0% | 0.00% | 0.0% |
| Q4 2014 | $5,000 | -44.4% | 7,000 | -65.0% | 0.00% | 0.0% |
| Q3 2013 | $9,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $9,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,250,840 | $1,013,000 | 0.07% |
| Benin Management CORP | 83,000 | $38,000 | 0.02% |
| WFG Advisors, LP | 20,000 | $9,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 40,230 | $19,000 | 0.00% |
| UBS AG | 1,000 | $0 | 0.00% |
| NOMURA HOLDINGS INC | 137,100 | $62,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 276,931 | $125,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 39,286 | $18,000 | 0.00% |
| Commonwealth Equity Services, Inc | 33,339 | $15,000 | 0.00% |
| Citadel Advisors | 42,132 | $19,000 | 0.00% |